Literature DB >> 29225207

Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case.

Yoko Omi1, Kiyomi Horiuchi1, Kento Haniu1, Momoko Tokura1, Erin Nagai1, Osamu Isozaki2, Yoji Nagashima3, Takahiro Okamoto1.   

Abstract

Primary hyperparathyroidism is the most common hormonal manifestation associated with multiple endocrine neoplasia 1 (MEN1). It is generally caused by parathyroid hyperplasia, and parathyroid carcinoma is rare. Here, we report a case of MEN1 with parathyroid carcinoma in two parathyroid glands causing primary hyperparathyroidism. A 40-year-old man with primary hyperparathyroidism due to MEN1 underwent a total parathyroidectomy. His corrected calcium and intact PTH (i-PTH) serum levels were 10.8 mg/dL and 203 pg/mL, respectively. Although three glands were successfully removed, the left upper parathyroid gland could not be detected. Since the right lower parathyroid lesion had invaded into the thyroid, right lobectomy was performed. A portion of the left lower parathyroid tissue was transplanted into his forearm. The histological findings of the left lower and the right upper parathyroid glands were consistent with hyperplasia while that of the right lower parathyroid gland was parathyroid carcinoma. Since the post-surgical i-PTH levels remained high, the intrathyroidal lesion of the left lobe, which was initally diagnosed as an adenomatous nodule, was suspected to contain parathyroid tumor. A fine needle aspiration of the tumor revealed a high concentration of i-PTH. One week after the first surgery, a left thyroid lobectomy was performed. The pathological diagnosis of the tumor was parathyroid carcinoma. After the surgery, calcium and i-PTH levels were normal. Although it is rare, parathyroid carcinoma should be considered as a cause of hyperparathyroidism in MEN1 patients. Since it is difficult to diagnose parathyroid carcinoma before surgery, intraoperative findings are important for the appropriate treatment.

Entities:  

Keywords:  Multiple endocrine neoplasia 1; Parathyroid carcinoma; Primary hyperparathyroidism

Mesh:

Substances:

Year:  2017        PMID: 29225207     DOI: 10.1507/endocrj.EJ17-0409

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  5 in total

1.  Parathyroid carcinoma in multiple endocrine neoplasm type 1 syndrome: case report and systematic literature review.

Authors:  Giovanna Di Meo; Lucia Ilaria Sgaramella; Valentina Ferraro; Francesco Paolo Prete; Angela Gurrado; Mario Testini
Journal:  Clin Exp Med       Date:  2018-06-20       Impact factor: 3.984

Review 2.  Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations.

Authors:  Chiara Mele; Monica Mencarelli; Marina Caputo; Stefania Mai; Loredana Pagano; Gianluca Aimaretti; Massimo Scacchi; Alberto Falchetti; Paolo Marzullo
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-18       Impact factor: 5.555

3.  Case Report and Systematic Review: Sarcomatoid Parathyroid Carcinoma-A Rare, Highly Malignant Subtype.

Authors:  Yongchao Yu; Yue Wang; Qingcheng Wu; Xuzi Zhao; Deshun Liu; Yongfu Zhao; Yuguo Li; Guangzhi Wang; Jingchao Xu; Junzhu Chen; Ning Zhang; Xiaofeng Tian
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-15       Impact factor: 5.555

4.  Gonadotrophin-releasing hormone agonist-induced pituitary adenoma apoplexy and casual finding of a parathyroid carcinoma: A case report and review of literature.

Authors:  Vanessa Triviño; Olga Fidalgo; Antía Juane; Jorge Pombo; Fernando Cordido
Journal:  World J Clin Cases       Date:  2019-10-26       Impact factor: 1.337

5.  Prevalence of Parathyroid Carcinoma and Atypical Parathyroid Neoplasms in 153 Patients With Multiple Endocrine Neoplasia Type 1: Case Series and Literature Review.

Authors:  An Song; Yi Yang; Shuzhong Liu; Min Nie; Yan Jiang; Mei Li; Weibo Xia; Ou Wang; Xiaoping Xing
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-30       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.